Intravenous Immunoglobulin and Dermatomyositis-Associated Venous Thromboembolism.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2023.1105
Abstract: This cohort study investigated the association between treatment of dermatomyositis with intravenous immunoglobulin and thromboembolic events. read more here.
Keywords: immunoglobulin dermatomyositis; dermatomyositis associated; associated venous; venous thromboembolism ... See more keywords
Anticoagulant treatment of cancer‐associated venous thromboembolism: Interpreting real‐world data with caution
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Hematology"
DOI: 10.1002/ajh.25164
Abstract: No abstract is available for this article. This article is protected by copyright. All rights reserved. read more here.
Keywords: associated venous; venous thromboembolism; thromboembolism interpreting; treatment cancer ... See more keywords
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-024-02992-1
Abstract: Treating cancer-associated venous thromboembolism (CAT) with anticoagulation prevents recurrent venous thromboembolism (rVTE), but increases bleeding risk. To compare incidence of rVTE, major bleeding, and all-cause mortality for rivaroxaban versus low molecular weight heparin (LMWH) in… read more here.
Keywords: cancer; rivaroxaban; venous thromboembolism; associated venous ... See more keywords
Recurrent Thrombosis and Bleeding in Patients with Cancer-Associated Venous Thromboembolism Receiving Anticoagulation: Are These Modifiable Risk Factors for Mortality?
Sign Up to like & getrecommendations! Published in 2023 at "Thrombosis and Haemostasis"
DOI: 10.1055/a-2015-8597
Abstract: Patients with cancer associated venous thromboembolism (VTE) have a higher risk of recurrent VTE than those without cancer and require long-term anticoagulation, but these patients are also at higher risk of anticoagulant-related bleeding because of… read more here.
Keywords: patients cancer; associated venous; venous thromboembolism; risk ... See more keywords
Major Bleeding Risk Assessment in Patients with Cancer-Associated Venous Thromboembolism Treated with DOACs: Data from a Multicenter Cohort
Sign Up to like & getrecommendations! Published in 2025 at "Thrombosis and Haemostasis"
DOI: 10.1055/a-2605-9015
Abstract: Background In cancer-associated venous thromboembolism (CAT), extended anticoagulation should be considered when the risk–benefit profile is favorable. However, optimal predictors of major bleeding (MB) remain unclear. Methods This multicenter observational study included CAT patients treated… read more here.
Keywords: cancer; bleeding risk; risk; venous thromboembolism ... See more keywords
Retrospective evaluation of the efficacy and safety of rivaroxaban in patients with cancer-associated venous thromboembolism
Sign Up to like & getrecommendations! Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000016514
Abstract: Abstrct The purpose of this study was to evaluate the efficacy and safety of rivaroxaban for the treatment of cancer-associated venous thromboembolism (VTE). We performed a retrospective chart review of cancer patients with a pulmonary… read more here.
Keywords: efficacy safety; cancer associated; cancer; associated venous ... See more keywords
Efficacy and safety of rivaroxaban compared to enoxaparin in treatment of cancer‐associated venous thromboembolism
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Haematology"
DOI: 10.1111/ejh.13074
Abstract: Low molecular weight heparin (LMWH) is the guideline‐endorsed treatment for cancer‐associated venous thromboembolism (cVTE). Study objectives were to compare the efficacy and safety of rivaroxaban and enoxaparin in cVTE. read more here.
Keywords: safety rivaroxaban; efficacy safety; associated venous; venous thromboembolism ... See more keywords
Prognosis in patients with cancer‐associated venous thromboembolism: Comparison of the RIETE‐VTE and modified Ottawa score
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.14783
Abstract: The RIETE‐VTE score was derived to risk‐stratify patients with cancer‐associated venous thromboembolism (CAT). read more here.
Keywords: associated venous; patients cancer; venous thromboembolism; cancer associated ... See more keywords
Cancer‐associated venous thromboembolism: Incidence and features in a racially diverse population
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15818
Abstract: Data on the population‐based incidence of cancer‐associated venous thromboembolism (VTE) from racially diverse populations are limited. read more here.
Keywords: racially diverse; incidence; associated venous; venous thromboembolism ... See more keywords
Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism
Sign Up to like & getrecommendations! Published in 2018 at "BMJ Evidence-Based Medicine"
DOI: 10.1136/bmjebm-2018-111007
Abstract: Commentary on : Raskob GE, van Es N, Verhamme P, et al . Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med . 2018 Feb 15;378:615–624. Low-molecular-weight heparin (LMWH) is the standard of… read more here.
Keywords: low molecular; associated venous; venous thromboembolism; cancer ... See more keywords
Clinical controversies in the treatment of cancer-associated venous thromboembolism
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155220984371
Abstract: Cancer-associated venous thromboembolism (VTE) is a common complication of malignancy. Patients with cancer exhibit risk factors for both recurrent VTE and major or minor bleeding. Direct oral anticoagulants (DOACs) are an attractive treatment option; however,… read more here.
Keywords: associated venous; venous thromboembolism; treatment cancer; cancer ... See more keywords